August 5, 2015 | The Israeli delayed release pharmaceuticals company Intec Pharma announced that it raised $27 million at a share price on $6 per share. The company raised the funds on NASDAQ at a company value of $60.6 million. Intec Pharma has developed an Accordion Pill, or medication that settles the stomach to slowly release drugs in the intestinal tract. Intec Pharma was founded in 2000 and is based in Jerusalem.
Related posts
AI Can Predict Future Heart Attacks By Analyzing CT Scans
October 01, 2023
Israeli Startups Create Powerful Drone-Detecting Software
September 28, 2023
Model Sees Daylight As Boost For Hospitalized Patients’ Health
September 28, 2023
Solar Panels On A Roll Certified As Safe For Use In US, Europe
September 28, 2023
Facebook comments